Quellen für medizinsche Inhalte

Quellen

Gelbe Liste - Verzeichnis von Medikamenten und Wirkstoffen, https://www.gelbe-liste.de
Rote Liste - Verzeichnis von Medikamenten und Wirkstoffen, https://www.rote-liste.de
Fachinformationsverzeichnis, https://www.fachinfo.de
Beers - Liste - ein Instrument zur Optimierung der Arzneimitteltherapie geriatrischer Patienten. MMP.2007, 7:244-248
FORTA - Liste nachweislich nützlicher und untauglicher Medikamente für ältere Patienten
PRISCUS - Liste, Deutsches Ärzteblatt 2020; 107 (31-32): 543-51

Publikationen zur klinischen Anwendung der DiGA

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study.
Del Casale A, et al.; J Pers Med. 2022. PMID: 35207804

Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN.
"Martocchia A, et al.; SN Compr Clin Med. 2021. PMID: 34977463

Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients.
Preissner SH, et al.; Eur J Clin Pharmacol. 2021. PMID: 34958399

Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
Occhipinti M, et al.; J Pers Med. 2021. PMID: 34069851

Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN System Comprehensive Approach.
Roberto M, et al.; Pharmaceuticals (Basel). 2021. PMID: 33467633

An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report).
Panebianco M, et al.; Curr Oncol. 2021. PMID: 34070464

Individualized Drug Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process.
Borro M, et al.; Pharmgenomics Pers Med. 2021. PMID: 34385834